Qube Research & Technologies »

Neuropace shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $23k 2.4k 9.73
2021-12-31 $192k 19k 10.06

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Neuropace

OrbiMed Advisors
Soleus Capital Management
Nantahala Capital Management
Kent Lake Capital
Vanguard Group
Millennium Management
Jane Street
Citigroup
Bank of America Corporation
Balyasny Asset Management
683 Capital Management
Citadel Advisors
Laurion Capital Management
Man Group
Townsquare Capital

View all funds holding Neuropace